Collection
MeSH Terms
English Title Translation
Neurological manifestations in COVID-19
Keywords
SARS-CoV-2, COVID-19, Long-COVID-Symptomatik, Post-COVID-Symptomatik, SARS-CoV-2-Impfung, Anosmie, Hyposmie, Parosmie, Phantosmie, Ageusie, Hypogeusie, Epidemiologie, Enzephalopathie, Zytokinsturm, Enzephalitis, epileptische Anfälle, Anfallsrezidiv, Arzneimittelinteraktionen, Fatigue, Kognition, Meningoenzephalitis, Myelitis, Enzephalomyelitis, neuromuskuläre
Erkrankungen, Myositis, Myasthenia gravis, Guillain-Barré-Syndrom, MillerFisher-Syndrom, critical illness weakness, critical illness neuropathy, critical illness myopathy, Intensive Care Unit-acquired weakness, ECMO, Beatmung, Aufwachreaktion, Delir, Status epilepticus, Neuromonitoring, Schlaganfall, intrazerebrale Blutung, intrakranielle Blutung, Vakzin-induzierte immunogene
thrombotische Thrombozytopenie (VITT), Sinus- und Hirnvenenthrombose, Fatigue, ME/CFS
Erkrankungen, Myositis, Myasthenia gravis, Guillain-Barré-Syndrom, MillerFisher-Syndrom, critical illness weakness, critical illness neuropathy, critical illness myopathy, Intensive Care Unit-acquired weakness, ECMO, Beatmung, Aufwachreaktion, Delir, Status epilepticus, Neuromonitoring, Schlaganfall, intrazerebrale Blutung, intrakranielle Blutung, Vakzin-induzierte immunogene
thrombotische Thrombozytopenie (VITT), Sinus- und Hirnvenenthrombose, Fatigue, ME/CFS
Date for Review
14/01/2029
Record Publish Year
2021
Publication Date
14/02/2024
Guideline Contact
Ina Kopp (imwi@awmf.org)
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2024